December 11th, 2017
jobs
homes

Menu
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Integra LifeSciences Holdings Corporation - Common Stock (NQ:IART)

14.80 +0.83 (+5.94%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Integra LifeSciences Holdings Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2023
 
Via Benzinga
BJ's Wholesale, Kingsoft Cloud, Zoom Video And Other Big Stocks Moving Lower On Tuesday
U.S. stocks traded mixed, with the Nasdaq Composite dropping around 30 points on Tuesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Why Integra LifeSciences Stock Is Tumbling
Integra LifeSciences Holdings Corp (NASDAQ: IART) shares are trading lower Tuesday after the company initiated a voluntary global recall.  
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Analyst Ratings for Integra Lifesciences
 
Via Benzinga
Integra Lifesciences Earnings Perspective: Return On Capital Employed
 
Via Benzinga
Why Integra LifeSciences (IART) Stock Is Plunging Today
Integra LifeSciences Holdings Corp (NASDAQ: IART) reported  
Via Benzinga
First Republic Bank, Activision Blizzard, Enphase Energy And Other Big Stocks Moving Lower On Wednesday
U.S. stocks traded mixed, with the Nasdaq Composite gaining over 100 points on Wednesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Wall Street Is Bullish on GE HealthCare as It Invests in AI
The stand-alone company that spun off from GE in January is off to a good start. 
Via The Motley Fool
KB Home, Bed Bath & Beyond And 3 Stocks To Watch Heading Into Wednesday
With US stock futures trading mixed this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
What 6 Analyst Ratings Have To Say About Integra Lifesciences
 
Via Benzinga
Integra Lifesciences's Return On Capital Employed Overview
Pulled from Benzinga Pro data, Integra Lifesciences (NASDAQ:IART) posted Q3 earnings of $49.91 million, an increase from Q2 of 11.45%. Sales dropped to $385.19 million, a 3.17% decrease between... 
Via Benzinga
Integra LifeSciences Shares Surge On Q3 Beat
 
Via Benzinga
Expert Ratings for Integra Lifesciences
Within the last quarter, Integra Lifesciences (NASDAQ:IART) has observed the following analyst ratings: 
Via Benzinga
Analyst Ratings for Integra Lifesciences
Within the last quarter, Integra Lifesciences (NASDAQ:IART) has observed the following analyst ratings: 
Via Benzinga
Integra Lifesciences: Q3 Earnings Insights
Integra Lifesciences (NASDAQ:IART) reported its Q3 earnings results on Wednesday, October 26, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022
Upgrades 
Via Benzinga
Integra LifeSciences Recalls CereLink Intracranial Pressure Monitors, Revises Guidance
 
Via Benzinga
Piper Sandler Cuts Price Target For Integra Lifesciences As It Divests Wound Care Portfolio
 
Via Benzinga
4 Analysts Have This to Say About Integra Lifesciences
Over the past 3 months, 4 analysts have published their opinion on Integra Lifesciences (NASDAQ:IART) stock. These analysts are typically employed by large Wall Street banks and tasked with... 
Via Benzinga
Integra Lifesciences's Return on Invested Capital Insights
According to Benzinga Pro, during Q2, Integra Lifesciences (NASDAQ:IART) earned $44.79 million, a 36.13% increase from the preceding quarter. Integra Lifesciences also posted a total of $397.81 million... 
Via Benzinga
Recap: Integra Lifesciences Q2 Earnings
  Integra Lifesciences (NASDAQ:IART) reported its Q2 earnings results on Wednesday, July 27, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 25, 2022
Upgrades 
Via Benzinga
Integra LifeSciences Posts Street Beating Earnings, Backs FY22 Guidance
 
Via Benzinga
Looking Into Integra Lifesciences's Return On Capital Employed
According to Benzinga Pro, during Q1, Integra Lifesciences (NASDAQ:IART) earned $32.90 million, a 27.51% increase from the preceding quarter. Integra Lifesciences's sales decreased to $376.64 million,... 
Via Benzinga
Integra Lifesciences: Q1 Earnings Insights
Integra Lifesciences (NASDAQ:IART) reported its Q1 earnings results on Wednesday, April 27, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
The Week Ahead In Biotech (April 24-April 30): Bristol-Myers Squibb, Supernus, Hutchmed, Axsome, Coherus FDA Decisions, Big Pharma Earnings, IPOs And More
Biotech stocks extended their loses in the week ending April 22. The sector took cues from the broader market, which reacted to the lackluster start of the first-quarter reporting season and lingering... 
Via Benzinga
Recap: Integra Lifesciences Q4 Earnings
Integra Lifesciences (NASDAQ:IART) reported its Q4 earnings results on Wednesday, February 23, 2022 at 06:00 AM. Here's what investors need to know about the... 
Via Benzinga
Price Over Earnings Overview: Integra Lifesciences
Right now, Integra Lifesciences Inc. (NASDAQ:IART) share price is at $67.58, after a 1.75% decrease. Over the past month, the stock spiked by 1.91%, but over the past year... 
Via Benzinga
A Peek Into The Markets: US Stock Futures Edge Higher Ahead Of Consumer Price Index
Pre-open movers U.S. stock futures traded higher in early pre-market trade after the Nasdaq jumped more than 200 points in the previous session. Investors are awaiting earnings... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.